Patent Law Weblog
recent posts
- Apple v. Squires: USPTO Director Has Unlimited Discretion on IPR Institution
- The Ghost in the Machine: Why GenAI Can Be Both a Brilliant Researcher and a Terrible Advocate
- Bayer Files Suit Against Trio of COVID-19 Vaccine Makers
- Allen v. Cooper (4th Cir. 2026)
- To Require an Inventor ID, or Not to Require an Inventor ID – That Is the Question
about
Month: September 2007
-
By Kevin E. Noonan — The Federal Circuit today affirmed a District Court finding that ANDA filer Ivax Pharmaceuticals and co-Defendant Cipla had not shown by clear and convincing evidence that Forest Laboratories’ patent-in-suit for Lexapro® was invalid. In doing so, the CAFC answered (for now) the question of whether a patent on…
-
By Donald Zuhn — On August 21, 2007, the U.S. Patent and Trademark Office published new rules concerning continuation and claims practice that will undoubtedly have a profound effect on the way patent attorneys and agents prosecute applications before the Patent Office. In view of the 128-page Federal Register notice regarding the new…
-
By Donald Zuhn — On August 21, 2007, the U.S. Patent and Trademark Office published new rules concerning continuation and claims practice that will undoubtedly have a profound effect on the way patent attorneys and agents prosecute applications before the Patent Office. In view of the 128-page Federal Register notice regarding the new…
-
By Kevin E. Noonan — As reported earlier by a variety of news sources, the J. Craig Venter Institute published today the sequence of a complete diploid human genomic complement, fitting that of the eponymous Dr. Venter (below), on the Public Library of Science (PLoS) website. This sequence differs in several ways from…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring.Ocular Research of Boston, Inc. v. Allergan2:07-cv-00385; filed August 31, 2007 in the Eastern District of Texas Infringement of U.S. Patent No. 5,578,586…
-
An Analysis of the New Rules: 37 C.F.R. § 1.78(d)(1): Claims for Benefit of Prior-Filed Applications
By Donald Zuhn — On August 21, 2007, the U.S. Patent and Trademark Office published new rules concerning continuation and claims practice that will undoubtedly have a profound effect on the way patent attorneys and agents prosecute applications before the Patent Office. In view of the 128-page Federal Register notice regarding the new…
-
September 6, 2007 – Assessing the New USPTO Multi-Patent Rules (West LEGALworks) September 6-7, 2007 – Emerging Issues in Biotechnology Law (American Law Institute & American Bar Association) – Washington, D.C. September 12, 2007 – Biotechnology/Chemical/Pharmaceutical Customer Partnership Meeting (U.S. Patent and Trademark Office) September 18, 2007 – Trying a Patent Validity Case in a…
-
Practising Law Institute (PLI) will be offering a webcast entitled: "Trying a Patent Validity Case in a Post-KSR World" on September 18, 2007 from 1:00-2:00 PM (EST). Speakers Keith L. Slenkovich of Thelen Reid Brown Raysman & Steiner LLP, Douglas R. Nemec of Skadden Arps Slate Meagher & Flom, and Mark D. Flanagan of Wilmer…
-
West LEGALworks® will be offering a webcast entitled: "KSR International Co. v. Teleflex, Inc.: Where Do We Stand Five Months Out?" on September 20, 2007 from 1:00-3:00 PM (EST). Speakers Thomas C. Goldstein and Jeffrey K. Sherwood of Akin Gump Strauss Hauer & Feld LLP and Robert Greene Sterne and Kenneth C. Bass, III of…
-
Practising Law Institute (PLI) will be offering a webcast on the final USPTO rules on claims and continuations on September 19, 2007 from 1:00-2:00 PM (EST). Speakers Robert J. Spar, former Director of the Office of Patent Legal Administration of the U.S. Patent and Trademark Office, and John M. White, Director of Patent Professional Development…
Patent Docs 